Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201401028 Principal Investigator: Govindan, Ramaswamy
Title: A phase I open-label, dose escalation study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of GSK2879552 given orally in subjects with relapsed/refractory small cell lung carcinoma
Phase: I Disease Site: Lung
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to test the safety of GSK2879552 at different doses. We want to find out what effects, good or bad, it has on people with small cell lung cancer.
 
More Information:
ClinicalTrials.Gov Link
Internal Protocol Documents (requires Siteman administrative database password)